small molecule therapeutic for basal cell carcinoma (Tri-I TDI/Bridge Medicines)

N/A

Report date: 2025/03/20 09:48:54
NME

Base Information

Drug Namesmall molecule therapeutic for basal cell carcinoma (Tri-I TDI/Bridge Medicines)
Drug Alias Namesmall molecule therapeutic for basal cell carcinoma (Rockefeller University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Rockefeller University
China Registration ClassN/A

Develop Information

Active CompaniesBridge Medicines IncTri-Institutional Therapeutics Discovery Institute
Inactive CompaniesThe Rockefeller University
Active IndicationsCarcinoma, Basal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A